$44.96
+0 (+0%)
At Close: Oct 30, 2024
CERE Stock: Over 9% Increase Pre-Market Explanation
08:55am, Tuesday, 13'th Apr 2021
The stock price of Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) increased by over 9% pre-market. This is why it happened.
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q4 2020 Results - Earnings Call Transcript
11:48am, Wednesday, 24'th Mar 2021
Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q4 2020 Results - Earnings Call Transcript
Cerevel Therapeutics to Host Investor Webcast Moderated by Stifel
07:00am, Friday, 04'th Dec 2020
CAMBRIDGE, Mass., Dec. 04, 2020 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced it wi
Sign In
Buy CERE